SCHEMBL17853634

SCHEMBL17853634

c1ccc(-c2nc(-c3cc(-n4c5ccccc5c5ccccc54)cc(-n4c5ccccc5c5ccccc54)c3)cc(-c3ccccc3-c3ncncn3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ MAOB P27338 5/20 0.35
▸ MEN1 O00255 6/20 0.34
▸ KMT2A Q03164 6/20 0.34
▸ MAPT P10636 4/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ NTSR1 P30989 1/20 0.34
▸ LMNA P02545 3/20 0.34
▸ POLB P06746 1/20 0.34
▸ CYP1A2 P05177 3/20 0.33
▸ CYP2C19 P33261 3/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ MAOA P21397 2/20 0.33
▸ MAPK10 P53779 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17853513 0.91 MAPT (0.40) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL17853636 0.89 KMT2A (0.42) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL17853628 0.89 MAPK13 (0.37) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL18820837 0.88 KDM4E (0.41) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL17853630 0.87 MEN1 (0.39) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL17853618 0.85 TSHR (0.40) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL17853601 0.85 MAPT (0.44) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL30019971 0.84 MEN1 (0.47) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL2758574 0.84 MEN1 (0.47) KDM4EATML3MBTL1MAOBMEN1
SCHEMBL17899202 0.83 TUBB4A (0.42) KDM4EATML3MBTL1MAOBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160181564-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, PIEZO1, SLC39A11 KDM4E 2180/4885ATM 3426/4885L3MBTL1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback